9780889374966 - clinical handbook of psychotropic drugs (1 Ergebnisse)
- Softcover
Anbieter: AHA-BUCH GmbH, Einbeck, DeutschlandAHA-BUCH GmbH
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Gebraucht - Sehr gut
EUR 74,55
EUR 67,03 VersandVersand von Deutschland nach USAAnzahl: 3 verfügbar
Spiralbindung. Zustand: Sehr gut. Gebraucht - Sehr gut SG - leichte Beschädigungen oder Verschmutzungen, ungelesenes Mängelexemplar, gestempelt - The Clinical Handbook of Psychotropic Drugs has become a standardreference and working tool for psychiatrists, psychologists, physicians, pharmacists, nurses, and other mental health p…rofessionals. - Independent, unbiased - Packed with unique, easy-to-read comparison charts and tables (dosages, side effects, pharmacokinetics, interactions.) for a quick overview of treatment options - Succinct, bulleted information on all classes of medication: on- and off-label indications, side effects, interactions, pharmacodynamics, precautions in the young, the elderly, and pregnancy, nursing implications, and much more - all you need to know for each class of drug - Potential interactions and side effects summarized in comparison charts - With instantly recognizable icons and in full color throughout, allowing you to find at a glance all the information you seek - Clearly written patient information sheets available for download as printable PDF files This book is a must for everyone who needs an up-to-date, easy-touse, comprehensive summary of all the most relevant information about psychotropic drugs. New in this edition: - Third-generation antipsychotics with major additions and changes - Pharmacogenomics fully revised - ECT thoroughly revised and updated - BLT / rTMS with extended references - Extrapyramidal side effects chart extended - Antidepressants vilazodone and vortioxetine with extended coverage - New chart of agents under investigation for treatment of substance use disorders - Approved and off-label indications updated - New unapproved treatments with significant updates, including anti-inflammatories, hormones, and 5-HT3 antagonists, in depression, dementia, schizophrenia, and anxiety disorders - New agents include: TGAs N-arylpiperazine (brexiprazole, Rexulti) and phenylpiperazine: (cariprazine, Vrylar), hypnotic suvorexant (Belsomra) - New formulations and tradenames include: Brisdelle (paroxetine mesylate), Irenka (duloxetine capsules), Invega Trinza, Dyanavel XR, Evekeo, Zenzedi, Adzenys XR-ODT, Aptensio XR, Quillichew ER / Quillivant XR.
